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ABSTRACT
The Arabidopsis thaliana decapping enzyme
(AtDcp2) was characterized by bioinformatics ana-
lysis and by biochemical studies of the enzyme and
mutants produced by recombinant expression.
Three functionally significant regions were
detected: (i) a highly disordered C-terminal region
with a putative PSD-95, Discs-large, ZO-1 (PDZ)
domain-binding motif, (ii) a conserved Nudix
box constituting the putative active site and
(iii) a putative RNA binding domain consisting of
the conserved Box B and a preceding loop region.
Mutation of the putative PDZ domain-binding motif
improved the stability of recombinant AtDcp2 and
secondary mutants expressed in Escherichia coli.
Such recombinant AtDcp2 specifically hydrolysed
capped mRNA to produce 7-methyl GDP and
decapped RNA. AtDcp2 activity was Mn
2+-o r
Mg
2+-dependent and was inhibited by the prod-
uct 7-methyl GDP. Mutation of the conserved
glutamate-154 and glutamate-158 in the Nudix
box reduced AtDcp2 activity up to 400-fold and
showed that AtDcp2 employs the catalytic mechan-
ism conserved amongst Nudix hydrolases. Unlike
many Nudix hydrolases, AtDcp2 is refractory to
inhibition by fluoride ions. Decapping was depen-
dent on binding to the mRNA moiety rather than to
the 7-methyl diguanosine triphosphate cap of the
substrate. Mutational analysis of the putative RNA-
binding domain confirmed the functional signi-
ficance of an 11-residue loop region and the
conserved Box B.
INTRODUCTION
One of the key processes in mRNA turnover is decapping,
that is, the removal of the 7-methyl guanosine cap from
the 50 end of the mRNA strand. Capped mRNA is
estimated to constitute 95–97% of cellular mRNA and it
has been proposed that the availability of the 7-methyl
guanosine cap in mRNA is a dominant feature in
competition for limited translation initiation factors,
primarily eIF4E (1). Cap-independent translation
mechanisms such as re-initiation and internal initiation
generally lack the eﬃciency associated with cap-dependent
translation (1). Since capping is co-transcriptional and
occurs in the nucleus (2), while decapping occurs
in granules known as the mRNA processing bodies
(P bodies) (3,4), decapped mRNAs are unlikely to be
recapped for cap-dependent translation. Rather, dead-
enylation followed by removal of 7-methyl guanosine
diphosphate from the 50 end of mRNA appears to initiate
degradation of mRNA by exoribonucleases in the 50 to
30 direction (5). There are four primary pathways of
mRNA decay in eukaryotes: two deadenylation-
dependent mechanisms classiﬁed in accordance to the
orientation of decay—50!30 or 30!50, endonucleolytic
digestion and quality control pathways (6). Of these,
deadenylation followed by decapping is the pathway
gaining importance in yeast, humans and now in plants
as a mechanism of controlling both gene expression and
protein synthesis (5,7,8).
In yeast, the major mRNA decay pathway involves
a deadenylation-dependent decapping mechanism, where
the mRNA is initially deadenylated, then decapped by an
enzyme named Dcp2p and ultimately degraded by a highly
processive exoribonuclease in the 50!30 direction (5,9–11).
A similar enzyme in humans, hDcp2, is active on capped
mRNA and is again deadenylation-dependent (7,12).
Although decapping by Dcp2 enzymes is a mandatory
step in the degradation of capped mRNA in the 50!30
direction, the mechanism of action of this enzyme is
still poorly understood and this enzyme is yet to be
characterized in plants. Annotation of the Arabidopsis
thaliana genome in the NCBI database includes one gene,
At5g13570, with strong sequence homology to the Dcp2-
type mRNA decapping enzymes. In this article, the
protein encoded by gene At5g13570 is studied in detail.
Dcp2-type decapping enzymes are members of the
Nudix superfamily of enzymes (13). Nearly 1800 open
reading frames coding for Nudix hydrolases have been
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(14). Nudix enzymes catalyse the hydrolysis of a wide
range of small nucleotide substrates composed of a
nucleoside diphosphate linked to another moiety X,
hence the name Nudix (14). All members of this super-
family share a conserved amino acid sequence
(GX5EX7REUXEEXGU) termed the Nudix motif/box,
forming the catalytic site of these enzymes (15,16). In the
Dcp2-type decapping enzymes from yeast and humans,
the Nudix box has been shown to be essential for the
hydrolysis of the pyrophosphate bond linking the cap
to the 50 extremity of mRNA (7,11).
It is proposed that hDcp2, the decapping enzyme from
humans, binds to the RNA body ﬁrst and subsequently
positions the active site against the cap structure for
decapping (17). An intact cap structure on an RNA strand
of 23 nucleotides is mandatory for decapping by hDcp2
(7). The hDcp2 enzyme is unable to bind to cap analog
[m
7G(50)ppp(50)G] alone (17) and decapping by hDcp2 is
not regulated by the addition of cap analog competitor
(7), again suggesting the importance of a short RNA
region for preliminary binding. In addition, uncapped
transcripts are eﬃcient competitors for capped RNA,
suggesting that binding of mRNA to hDcp2 is indepen-
dent of the cap itself (17). A region essential for RNA
binding by the hDcp2 protein was demonstrated by
deletion mutagenesis. The deleted region was C-terminal
to the Nudix motif in a region comprising an a-helical
structure and a preceding loop region (17,18). The region
corresponding to the above a-helix was designated as
Box B (17,18). The contributions of structural motifs and
individual residues to mRNA binding within this region
have not been established.
In vivo studies in plants suggest an important role
for the Dcp2 type decapping enzyme in post-embryonic
development (8,19). Heterozygous knockouts of the dcp2
allele coding for the AtDcp2 protein, which resulted
in small leaves and short hypocotyls and roots, and
homozygous T-DNA insertions, which resulted in a lethal
phenotype, demonstrate the signiﬁcance of the AtDcp2
decapping enzyme for growth and elongation of plants (8).
In this article, we present studies on the enzymatic
properties and structural motifs central to the mechanism
of action of this Dcp2-type decapping enzyme from the
plant A. thaliana and conﬁrm that gene At5g13570 does
indeed encode an active Dcp2-type decapping enzyme. We
conduct in addition a mutational analysis on AtDcp2 as a
full length recombinant protein. Previous biochemical
studies largely used truncated Dcp2 proteins with greater
inherent stability (11,17). Indeed, we detected signiﬁcant
proteolysis of the recombinant full length AtDcp2
expressed in E. coli. To minimize the proteolysis of the
full length AtDcp2 protein in a bacterial expression
system, we ﬁrst conducted bioinformatics analyses to
identify the structurally disordered regions that are
susceptible to proteolysis in the AtDcp2 sequence. In
addition to the regions with high propensity of structural
disorder, we also discovered a putative PSD-95, Discs-
large, ZO-1 (PDZ) domain-binding motif in the AtDcp2
sequence. This motif could potentially target the recom-
binant AtDcp2 protein to the PDZ domain-containing
proteases in Escherichia coli. Thus, its mutation to abolish
such interaction could minimize degradation of the
recombinant AtDcp2 protein in E. coli. We found that
mutation of the putative PDZ domain-binding motif did
minimize degradation of recombinant AtDcp2 protein in
E. coli. The adoption of such a strategy permits us to
express full length AtDcp2 protein and its mutants for
biochemical analysis.
Bioinformatics analysis was used to identify further
structural motifs within the sequence of the full length
AtDcp2 protein. The functional signiﬁcance of these
motifs was investigated by biochemical characterization
of the recombinant AtDcp2 mutants carrying mutations
of key residues in these motifs. The mechanism of
hydrolysis was investigated by mutation of key residues
in the consensus REXXEE found within the conserved
Nudix box of this enzyme superfamily. In addition,
biochemical analyses to decipher the molecular basis
of substrate recognition by AtDcp2 and the ability of
the reaction products to selectively suppress AtDcp2
decapping activity were conducted. Our results demon-
strated the involvement of a putative loop region and the
neighbouring Box B region in decapping.
MATERIALS AND METHODS
Bioinformatics analysis
Structural disorder prediction was performed with the
DISOPRED (20) and DisEMBL (21) disorder prediction
servers. Information on introns/exons and intron phases
was downloaded from the Xpro database (22). Homology
modelling of the 3D structures of proteins was performed




A cDNA library in the pSPORT-P vector prepared from
mRNA from 42-day-old seedlings of A. thaliana cv
Columbia was obtained from Invitrogen, USA. The
cDNA corresponding to the At5g13570 gene was ampli-
ﬁed by PCR from the Arabidopsis cDNA library with
primers introducing a BamH I site at the 50 end and an
EcoR I site at the 30 end. PCR reactions were performed in
50ml reaction volumes containing the PCR ampliﬁcation
buﬀer, 400nM of each dNTP, 100ng of the 50 and 30 gene-
speciﬁc primers, 2ml of the cDNA template and 1–5U of
Taq DNA polymerase (Invitrogen, USA). The cycling
conditions were 958C for 30s, 45–558C for 30–45s and
728C for 1min/kb of the expected products. The
ampliﬁcation conditions consisted of 25–40 cycles, with
ﬁnal 5min incubation at the end of the ampliﬁcation
cycles. PCR products were ligated into digested vectors
using the T4 DNA ligase (Roche, Switzerland). Reactions
were carried out with 10–100ng of the vector with 3- to
20-fold molar excess of the insert in the ligation buﬀer
supplied by the manufacturer. The ligation reactions
were incubated at 148C overnight and immediately used
for transformation of competent bacterial cells. Plasmid
puriﬁcation was performed using the PerfectPrep mini kit
(Eppendorf Scientiﬁc Inc., USA). The plasmid clones
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sequenced to conﬁrm authenticity of the insert and that
the insert was in frame for expression as a glutathione
S-transferase (GST)-fusion in E. coli.
Site-directed mutagenesis
The QuikChange
TM site-directed mutagenesis kit
(Stratagene, USA) was used to create the sequences
coding for the mutant proteins. PCR reactions comprised
of 40–180ng of plasmid DNA, 100ng of each mutagenic
primer, 200mM dNTPs, 10mM KCl, 6mM (NH4)2SO4,
20mM Tris–HCl and 2.5U of Pfu Turbo DNA poly-
merase in a total volume of 50ml. The reaction was
subjected to an initial heating step of 30s at 958C and
21 cycles of 958C for 30s, 558C for 1min, 688C for 14min
in a Geneamp
R PCR system (Perkin-Elmer, USA). A 5ml
aliquot of the reaction was obtained for analysis by
agarose gel electrophoresis and the remaining 45ml of the
reaction was subjected to digestion, with Dpn I endonu-
clease for 1–2h at 378C. A total of 1–10ml of the reaction
was used to transform 60mlo fE. coli XL1-Blue cells for
ampliﬁcation of the mutant plasmids. Mutant cDNAs
isolated from bacterial cells were sequenced to verify the
mutations.
In vitro transcriptionof mRNA
All transcripts were synthesized by in vitro transcription
using an SP6 polymerase. Omp (Outer membrane protein)
gene (Saccharomyces cerevisiae YBR230C) cloned into the
pSP73 vector, for SP6 driven transcription, was donated
by Dr Lena Burri. The Omp transcripts were synthesized
by SP6 polymerase driven transcription on linearized
plasmids using the MEGAscript in vitro transcription kit
(Ambion, USA) as described by the manufacturer.
Cappingreactions
The capping reaction mixture contained 50mM Tris–HCl,
pH 8, 6mM KCl, 2.5mM DTT, 1.25mM MgCl2,
0.1mg/ml BSA, 20 U RNaseOUT
TM ribonuclease inhi-
bitor, 0.4mM SAM, 3.33pmol (3000Ci/mmol) [a-
32P]
GTP and 10U of vaccinia virus capping enzyme (Ambion,
USA) in a ﬁnal volume of 200ml. The reactions were
incubated at 378C for 3h and the total RNA precipitated
with 3.25M LiCl. The precipitated RNA was resuspended
and dissolved in 200mlo fH 2O prior to its use as the
substrate for the decapping activity assay.
Expression andpurification of theAtDcp2 protein
Escherichia coli BL-21(DE3)pLysS transformed with the
wild-type/mutant plasmids was grown with orbital shak-
ing (180–200r.p.m.) at 378Ct oa nA 600nm of 0.3–0.6 and
induced with 0.5–1mM IPTG. Expression was induced
for 3–40h, depending on the post-induction temperature.
Post-induction temperatures ranging from 158Ct o3 7 8C
were used. Cells were harvested, sonicated to disrupt the
cells and the soluble and insoluble fractions separated
by centrifugation at 13000g for 15min. The expressed
GST-AtDcp2 and GST-AtDcp2-PD fusion proteins were
puriﬁed by aﬃnity chromatography on a glutathione
agarose column. The GST-AtDcp2-PD-His10 protein was
puriﬁed by aﬃnity chromatography using a Co-IDA
agarose column. The histidine-tagged fusion proteins were
supplemented with Tris(2-carboxyethyl) phosphine hydro-
chloride (TCEP) to a ﬁnal concentration of 5.7mM.
Decapping reaction and separation of thecomponents
ofthe decappingreaction by thin layer chromatography
Decapping of the capped mRNA by the AtDcp2 protein
was assayed in reactions containing 50mM Tris–HCl,
pH 8, 5mM MnCl2 or 5mM MgCl2, 0.0167pmol (ﬁnal
concentration 0.14nM) capped mRNA containing
32Pa t
the a-phosphate group ([a-
32P]-7-methyl-Gppp-RNA) and
up to 8mg of the decapping enzyme or its mutants in a
ﬁnal volume of 120ml. For comparative mutational
analyses, 8mg of the recombinant enzyme was used for
each reaction. All assays were conducted using the capped
Omp mRNA transcripts of 548 nucleotides. Reactions
were incubated at 258C for up to 3h. Aliquots (2ml) were
directly blotted onto PEI-Cellulose (Merck & Co. Inc.,
USA) and TLC performed using 0.75M LiCl or 0.45M
(NH)4SO4 as the mobile phase. The TLC plates were dried
and the distribution of radioactivity determined using
a Typhoon 8600 phosphorimager and ImageQuant 5.2
software (Amersham International, UK). The extent of
decapping at the respective time points was calculated
using the following formula.
% Decapping
¼
½a 32P  7 methyl GDP
½½a 32P  7 methyl GDP
þRemnant ½  32P  capped mRNA 
   100
For competition studies of mRNA decapping, reactions
were run with a ﬁxed amount (0.14nM) of radiolabelled
capped Omp mRNA and 164mM to 2mM of each non-
radioactive competitor. The competitors were uncapped
Omp mRNA, cap analog dinucleotide (7-methyl digua-
nosine triphosphate) and 7-methyl GDP. Inhibition of
decapping by ﬂuoride ions was assayed under standard
conditions in the presence of 50mM to 25mM NaF.
Identification of themajor reaction product of the
AtDcp2-catalysed decapping of cappedmRNA as
7-methyl-GDP
The radioactive capped mRNA ([a-
32P]-m
7Gppp-RNA)
was incubated with GST-AtDcp2-PD-His10 in the pre-
sence of Mn
2+ for a prolonged period of time (>3h)
to allow complete decapping of [a-
32P]-m
7Gppp-RNA by
the enzyme. An aliquot of the reaction mixture was mixed
with up to 1mg of 7-methyl-GDP standard prior to
application onto the TLC plate. After chromatography,
the 7-methyl-GDP standard on the TLC plate was
detected by Abs254nM and its location was marked and
the mobilities of the radioactive reaction products of the
decapping reaction were detected by autoradiography.
Co-migration of a radioactive spot with the 7-methyl-
GDP standard indicates that the radioactive spot
Nucleic Acids Research,2008, Vol. 36,No. 1 205corresponds to 7-methyl-GDP generated in the AtDcp2-




The recombinant AtDcp2 protein preparation from
expression in E.coli contains asignificant amount of
degradation products
The cDNA corresponding to gene At5g13570, annotated
in the NCBI database as a putative Dcp2 type mRNA
decapping enzyme from the genome of A. thaliana,
was ampliﬁed by PCR from a cDNA library prepared
from seedlings of A. thaliana cv Columbia. The encoded
protein, a putative Dcp2-type mRNA decapping enzyme,
was expressed in E. coli as a GST fusion protein, GST-
AtDcp2. Expression at post-induction temperatures of
238C and 378C did not produce any soluble GST-AtDcp2
protein. Co-expression with chaperones GroES and
GroEL did not signiﬁcantly increase the yield of soluble
GST-AtDcp2. When the expression temperature was
lowered to 158C, a signiﬁcant amount of soluble
GST-AtDcp2 protein was obtained. As shown in
Figure 1A, puriﬁcation by glutathione-agarose aﬃnity
chromatography generated an enzyme preparation that
contains the intact recombinant GST-AtDcp2 of  69kDa
and a signiﬁcant amount of lower molecular weight
contaminating proteins. As all the proteins bound to
glutathione agarose, we therefore conclude that the
contaminating proteins retained an intact N-terminal
GST moiety and were degradation products of the
recombinant protein with a portion of the C-terminus
end truncated. The most likely source of these contam-
inating proteins was either proteolysis of the C-terminal
end of the proteins following expression or premature
termination of translation. In agreement with our obser-
vation, extensive proteolysis of the decapping enzymes
from yeast (Dcp2p) and human (hDcp2) was observed
when these proteins were expressed as recombinant
proteins in bacterial expression systems (7,11).
Bioinformatics analysis revealed structural disorder
andidentified aputative PDZ domain-binding motif at
theC-terminus
Since the puriﬁed GST-AtDcp2 preparation contained a
signiﬁcant amount of proteolytic products, we conducted
a bioinformatics analysis to identify regions in the AtDcp2
sequence that are prone to proteolysis. The rationale is
that mutation or deletion of the putative proteolysis-prone
regions may allow generation of intact recombinant
AtDcp2 proteins for biochemical analysis. Our analysis
revealed a region of extensive structural disorder at the
C-terminus of the AtDcp2 protein. Seventy-six percent
of the C-terminus from residues 251–373 was predicted
by DISOPRED (20) to be disordered, while only 8%
of the N-terminal region spanning residues 1–250 was
disordered. The C-terminus was similarly predicted by
DisEMBL (21) to contain a high percentage of structural
disorder in the form of loops and coils, hot loops that
constitute a subset of loops comprising inherent high
mobility and missing coordinates in X-ray structures
(Figure 2A). In comparison to other segments in the
AtDcp2 sequence, the C-terminal extremity was predicted
to exhibit the highest degree of structural disorder.
From this analysis, it was concluded that there are two
topologically diﬀerent regions present in the AtDcp2
protein, a structured globular N-terminus and a highly
disordered C-terminus of 123 amino acids.
The presence of such a signiﬁcant region of structural
disorder is highly unusual for Nudix hydrolases. Most
members of the Nudix superfamily are compact globular
enzymes. When the structural disorder proﬁle of each of
the 25 members of the Nudix hydrolase superfamily in
A. thaliana was assessed, it was apparent that the AtDcp2
protein was the only Nudix protein in Arabidopsis to
possess a region with a high degree of structural disorder
(data not shown). To assess the genetic basis for the
presence of unique structural features at the protein level,
the intron–exon architecture of the At5g13570 gene,
coding for AtDcp2, was investigated. The majority of
the disordered C-terminal extremity of AtDcp2 was
encoded by a longer exon (coding for 111 residues)
comprising of a phase 1 intron at the 50 end and a minor
segment encoded by a smaller exon containing a phase 2
intron at the 50 end (Figure 2B). In contrast, the Nudix
fold contained phase 0 introns between exons (Figure 2B).
Whereas the presence of phase 0 introns in the Nudix fold
is consistent with its more ancient origins—it is found in
eukarya, prokarya and archaea—the phase 1 and 2 introns
found between exons forming the disordered C-terminus
of the decapping enzyme are consistent with its more
recent formation in the eukaryotic lineage alone.
The structural disorder within the AtDcp2 protein was
consistent with its putative role as an RNA chaperone that
Figure 1. SDS–PAGE analysis under non-reducing conditions of the puriﬁed variants of recombinant AtDcp2 enzyme expressed in E. coli.
(A) GST-AtDcp2. (B) GST-AtDcp2-PD. (C) GST-AtDcp2-PD-His10. The arrow indicates the mobility of the intact recombinant protein in each case.
206 Nucleic Acids Research, 2008, Vol. 36, No. 1binds to the unwound 50 RNA backbone prior to cap
hydrolysis. Large disordered regions are a characteristic
feature of RNA and protein chaperones (24). In the
AtDcp2 protein, this region of disorder maps outside of
the region inclusive of an a-helix named Box B and an
adjacent loop region that had previously been demon-
strated to be essential for RNA binding by the human
hDcp2 enzyme (17) and may function separately in RNA
binding. Many unfolded and misfolded regions of proteins
undergo proteolysis more readily than regions that adopt
well-deﬁned secondary and tertiary structures (25–27).
Thus, the presence of such a long C-terminal segment with
high propensity of structural disorder may contribute
to its susceptibility to proteolysis by the endogenous
proteases when expressed as a recombinant protein in
E. coli.
In addition to this, we have also identiﬁed another
structural feature that could potentially contribute to its
susceptibility to proteolysis in E. coli—the C-terminal
GNSA motif, which is a putative PDZ domain-binding
motif (Figure 2C). The GNSA motif could further
enhance proteolysis of recombinant AtDcp2 by directing
the recombinant protein to bind the PDZ domain-
containing proteases. PDZ domains are protein–protein
interaction domains, chieﬂy responsible for the binding of
partner proteins (28). The protein–protein interactions
mediated by PDZ domains rely on the low-binding aﬃnity
of PDZ domains to apolar PDZ domain-binding motifs
of partner proteins, in particular, those which contain a
hydrophobic residue at the C-terminal extremity (28).
Several of the cytoplasmic and periplasmic proteases in
E. coli responsible for the degradation of disordered or
misfolded proteins, contain PDZ or PDZ-like domains.
For example, both the tail-speciﬁc protease (Tsp) and the
isolated PDZ domain from the Tsp protease bind to the
apolar residues of substrates with a dissociation constant
KD of 1.8–1.9mM (29). Further, the periplasmic PDZ
domain-containing protease DegS preferentially recog-
nizes the sequence motif YYF-COOH at the C-terminal
extremity of protein substrates (30,31).
Taken together, the susceptibility of recombinant
AtDcp2 to proteolysis is likely due to the presence of
(i) a long segment with high propensity of structural
disorder and (ii) a putative PDZ domain-binding motif at
the C-terminus.
Mutation ofthe putative PDZ domain-binding motif
significantly reduces proteolysis ofthe recombinant AtDcp2
proteinexpressed inE. coli
The inclusion of broad-speciﬁcity proteases inhibitors in
the extraction buﬀer did not prevent proteolysis of the
recombinant GST-AtDcp2 protein (data not shown). We
decided to mutate the PDZ domain-binding motif of
AtDcp2 to minimize proteolysis of the recombinant
enzyme by the endogenous proteases in E. coli. The
C-terminal residues Ser-Ala were mutated to Pro-Asp to
replace the apolar tail with an acidic residue to abolish any
possible interaction of the recombinant enzyme with the
PDZ domain-containing proteases. Indeed, the resultant
mutant protein GST-AtDcp2-PD was less susceptible to
degradation than the parent molecule with an intact PDZ
domain-binding motif at the C-terminus. The puriﬁed
GST-AtDcp2-PD preparation (Figure 1B) contains pre-
dominantly the intact recombinant enzyme of  69kDa
and a much smaller amount of degradation products than
the GST-AtDcp2 preparation (Figure 1A). Consistent
with our observation, similar approaches (i.e. insertion of
a polar tail motif) was adopted by other researchers
Figure 2. Bioinformatics analysis predicts region of structural disorder
and existence of a putative PDZ binding domain in the AtDcp2
sequence. (A) Prediction of disordered regions using the DisEMBL
server—in the graphical output from DisEMBL, the disorder prediction
is calculated using the three criteria: (i) secondary structural types of
loops/coils (blue), (ii) hot loops which constitute a subset of loops
comprising inherent high mobility (red) and (iii) missing coordinates in
X-ray structures (green). (B) Schematic representation of the protein
fragments encoded by each exon of the At5g13570 gene coding for
AtDcp2 mRNA decapping enzyme—labels indicate the size of proteins
fragments encoded by each exon (below) and the intron phases (above)
of the At5g13570 gene. The positions of the Nudix fold and the
disordered tail are shown. (C) The sequence corresponding to the
disordered region of the AtDcp2 protein (underlined) with emphasis on
the putative PDZ domain-binding motif. (D) The putative PDZ
domain-binding motif in the wild-type AtDcp2 protein and mutations
introduced to generate the recombinant GST-AtDcp2-PD and GST-
AtDcp2-PD-His10 proteins.
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proteases containing PDZ or PDZ-like domains. For
example, the sequence KNQHE was attached to the
C-terminal extremity of the Arc repressor to abolish its
rapid proteolysis by the Tsp (32). Similarly, the presence
of a polar C-terminal extremity in the   repressor
N-terminal domain prevented its degradation by Tsp (32).
The inclusion ofapoly-histidine tagand theaddition of
tris-(2-carboxyethyl) phosphine hydrochloride (TCEP)
facilitatespurification andprevents aggregation of
recombinant AtDcp2 proteins
A poly-histidine tag (His10) was engineered at the
C-terminus of GST-AtDcp2-PD to facilitate puriﬁcation
of the intact recombinant AtDcp2 protein. The resultant
recombinant enzyme GST-AtDcp2-PD-His10 contains
(i) a GST moiety at the N-terminus, (ii) mutations of the
last two residues at the C-terminus of the AtDcp2
sequence and (iii) a poly-histidine tag at the C-terminus.
The presence of the poly-histidine tag permitted eﬃcient
puriﬁcation of the intact recombinant GST-AtDcp2-PD-
His10 proteins from crude bacterial lysate (Figure 1C).
We also included 5.7mM of TCEP in the buﬀer for
storage of the ﬁnal puriﬁed enzyme preparation to prevent
aggregation of the recombinant enzyme. A summary of
the further mutations carried out on GST-AtDcp2-PD-
His10 is shown in Figure 3
7-methylGDP isamajor product ofthe divalent
cation-dependent decappingreaction catalysed
byGST-AtDcp2-PD-His10
The activity of expressed GST-AtDcp2-PD-His10
protein as a decapping enzyme was assessed with an
assay procedure adapted from the method developed
by Zhang et al. (33). This method involves the use of
radioactive [a-
32P]-labelled capped mRNA (referred to as
[a-
32P]-m
7Gppp-RNA) as the substrate and separation of
the reaction products from the substrate by TLC. Since
longer capped transcripts (those of more than 99 bases)
were preferred over shorter capped transcripts (20–29
bases) by the yeast decapping enzyme Dcp2p (11), we
chose the yeast outer membrane protein (Omp) transcript
of 548 bases as the substrate for all decapping reactions
described in this article. To generate the capped RNA,
in vitro transcribed Omp mRNA was radiolabelled at
the a-phosphate group of the cap with [a-
32P] GTP using
a capping enzyme from vaccinia virus.
As shown in Figure 4A, GST-AtDcp2-PD-His10
catalysed formation of several radioactive reaction pro-
ducts from [a-
32P]-m
7Gppp-RNA in the presence of Mg
2+
or Mn
2+. These reaction products were separated by TLC
and depicted in the ﬁgure as spots a, b and c. Since [a-
32P]-
m
7Gppp-RNA could not migrate during chromatogra-
phy, it remained at the origin. Thus, the radioactive spot
at the origin corresponded to residual [a-
32P]-m
7Gppp-
RNA left at the end of the reaction. Among spots a, b and
c, spot b represents the major reaction product. To
identify reaction product in spot b, [a-
32P]-m
7Gppp-RNA
was incubated with GST-AtDcp2-PD-His10 in the pre-
sence of Mn
2+ for a prolonged period of time (>3h) to
allow complete decapping of [a-
32P]-m
7Gppp-RNA. An
aliquot of the reaction mixture was mixed with up to 1 mg
of 7-methyl-GDP standard prior to application onto the
TLC plate. After chromatography, the 7-methyl-GDP
standard on the TLC plate was detected by Abs254nM and
its location was marked (data not shown). When the
location of radioactive spots a, b and c on the TLC plate
was monitored by autoradiography, we found that spot b
co-localized with 7-methyl GDP (The key in Figure 4A),
Figure 3. Summary of the mutations and purity of the puriﬁed preparations of GST-AtDcp2-PD-His10 and its mutants. (A) The location of the
functional motifs and mutated residues in the AtDcp2 protein. All proteins also contained an additional 10 histidine residues C-terminal to residue
373. (B) SDS–PAGE analysis of the preparations of GST-AtDcp2-PD-His10 protein (His10) and mutant variants puriﬁed with buﬀers containing
TCEP to minimize aggregation. The single amino acid substitutions are presented using the conventional mutational nomenclature. Del 11 indicates
the mutant AtDcp2
 222–232. The arrow indicates the mobility of the intact recombinant proteins (molecular masses ranging from  67 to 69kDa).
208 Nucleic Acids Research, 2008, Vol. 36, No. 1suggesting that 7-methyl-GDP was generated in the
decapping reaction catalysed by GST-AtDcp2-PD-His10
in vitro.
When the conserved glutamate-154 essential for decap-
ping activity was replaced by alanine (the rationale of this
mutation is presented in the next section), the mutant
could only generate a negligible amount of spot b after
prolonged incubation (120min) (Figure 4B). Thus, the
generation of radioactive reaction products in spots a, b
and c from [a-
32P]-m
7Gppp-RNA as shown in Figure 4A
was indeed catalysed by the intrinsic enzymatic activity
of GST-AtDcp2-PD-His10 and not by the activity of any
contaminating enzyme in the protein preparation.
In addition to TLC analysis, the mixture generated
by prolonged incubation of [a-
32P]-m
7Gppp-RNA with
GST-AtDcp2-PD-His10 was subject to analysis by
SDS/urea polyacrylamide gel electrophoresis following
alkaline phosphatase treatment. It is noteworthy that free
inorganic phosphate migrates at the dye front, while the
migration of small nucleotides such as 7-methyl GMP
and 7methy GDP is retarded in the SDS/urea gel electro-
phoresis (34). Being a non-speciﬁc phosphatase, alkaline
phosphatase can fully dephosphorylate all possible






32P]-7-methyl GDP and [a-
32P]-7-methyl GTP. As
shown in Figure 4C, treatment of reaction mixture with




mixture without alkaline phosphatase treatment contained
a negligible amount of [
32P]-Pi.
Taken together, the results shown in Figure 4A–C
conﬁrmthat7-methylGDPandbyinference50-monophos-
phate mRNA, are the major products of the AtDcp2-
catalysed decapping reaction. In addition to the major
radioactive spot (spot b), corresponding to 7-methyl-
GDP, two minor radioactive spots (spots a and c) were
also detected in the TLC plate. Since they correspond to
Figure 4. Characterization of the mRNA decapping activity of AtDcp2. (A) TLC identiﬁcation of the products of hydrolysis by GST-AtDcp2-PD-
His10 protein of capped mRNA labelled with
32P at the a-phosphate of the cap. Reactions were carried out in the presence of 5mM Mg
2+ or 5mM
Mn
2+ and in the absence of both ions. The ‘key’ shows the mobilities of the standard 7-methyl GDP (corresponding to spot b) and capped mRNA
on the TLC plate. According to the report by Bergman et al. (34), spots a and c likely correspond to [
32P]7-methyl-GMP and [a-
32P]7-methyl-GTP,
respectively. (B) TLC proﬁle of the time course of decapping of [
32P]-labelled capped RNA by the GST-AtDcp2-PD-His10 mutant carrying
the catalytic site mutation (E154A) in the presence of 5mM Mn
2+ ions. (C) Twenty percent SDS/Urea polyacrylamide gel electrophoresis of
the products of the AtDcp2-catalysed decapping of [
32P]-labelled capped RNA before ( ) and after (+) treatment with alkaline phosphatase.
The multiple radioactive bands in the lane labelled ( ) correspond to [a-
32P]7-methyl-GDP and other nucleotides including [
32P]7-methyl-GMP
and [a-
32P]7-methyl-GTP generated in this extended (3h) decapping reaction. (D) Time course of decapping by the GST-AtDcp2-PD-His10 protein
in the presence of Mg
2+ or Mn
2+ determined by TLC as in panel A. In the absence of Mn
2+ and Mg
2+ ions, production of 7-methyl GDP was
undetectable (data not shown).
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catalysed decapping reaction, we did not conduct further
experiments to conﬁrm their identities. Comparison of
their mobilities in the TLC (Figure 4A) and those
reported by other researchers, spots a and c likely
correspond to 7-methyl GTP and 7-methyl GMP,
respectively. It is noteworthy that in all analyses, only
the radioactivity associated with spot b was used to
measure the decapping activity of AtDcp2 and its
mutants.
Both the human and the yeast decapping enzymes
require the presence of either Mg
2+ or Mn
2+ ions for
activity (11,17). For the human enzyme, Mn
2+ is the
preferred cofactor in vitro (17). For the truncated yeast
decapping enzyme Dcp2 Cp, both by itself and in the
presence of the yeast Dcp1p protein, Mn
2+ was the
preferred bivalent cation for decapping (11). The decap-
ping activity of the GST-AtDcp2-PD-His10 protein was
absolutely dependent on either Mn
2+ or Mg
2+ cofactors,
with activity four fold higher with Mn
2+ compared to
Mg
2+ (Figure 4D). Reaction rates show an initial rapid
rate of decapping followed by a second more gradual rate
of decapping (Figure 4D). Similar biphasic kinetics was
also observed for the yeast decapping enzyme Dcp2 Cp
in the presence of Dcp1p (11).
Fluorideions havelittle effect on thecatalytic activity
ofAtDcp2
Many Nudix hydrolases are highly susceptible to inhibi-
tion by ﬂuoride ions (35,36). Nudix enzymes active on
Ap4A, coenzyme A and ADP-ribose have been demon-
strated to be strongly inhibited by ﬂuoride ions (35,37,38).
The IC50 values for ﬂuoride inhibition for the Ap4A
hydrolase from Lupinus angustifolius, the coenzyme A
pyrophosphatase from Caenorhabditis elegans and ADP-
ribose pyrophosphatase from human were 3, 3 and 20mM
respectively, demonstrating that even at low micromolar
concentrations of ﬂuoride ions Nudix hydrolases are
strongly inhibited (35,37,38). In contrast to these, other
Nudix hydrolases, the GST-AtDcp2-PD-His10 protein
was not inhibited by ﬂuoride ions up to a concentration
1mM NaF (Figure 5A), and showed only a small
inhibition at 25mM NaF (Figure 5B). To determine if
the lack of inhibition was due to the presence of Mn
2+ as
cofactor, ﬂuoride sensitivity of AtDcp2 was also tested
in the presence of Mg
2+ ions. In the presence of Mg
2+
ions, there was no inhibition by ﬂuoride of concentrations
up to 1mM and there was only a minor inhibitory eﬀect in
the presence of 25mM NaF (Figure 5C). It was concluded
that the mRNA decapping enzyme from A. thaliana did
not show the exquisite sensitivity to ﬂuoride ions that
is characteristic of many Nudix hydrolases.
Mutation ofthe essential glutamates within
theNudix box abolishes decapping activity ofthe
AtDcp2 protein
In spite of its insensitivity to ﬂuoride ions, AtDcp2 retains
the catalytic mechanism characteristic of Nudix enzymes.
The key residues for catalysis within the catalytic site have
been previously investigated in many Nudix hydrolases.
Two glutamates, three residues apart in the conserved
sequence REXXEE have been shown to be signiﬁcant in
the hydrolysis of Nudix substrates. The ﬁrst glutamate in
the REXXEE sequence acts as a general base that
deprotonates a water molecule, which in turn attacks the
b-phosphorus of the substrate (39). The mutation of this
residue results in substantial loss of enzymatic activity
in Nudix hydrolases (40). The third glutamate in the
REXXEE sequence contributes a ligand to the enzyme-
bound bivalent cation cofactor (39,41). Disruption of the
third glutamate in the E. coli MutT enzyme induced a
dramatic loss in enzymatic activity (41).
The analogous glutamates (Glu-154 and Glu-158)
within the Nudix box of the AtDcp2 enzyme were mutated
to alanine, as single substitution mutations. As shown
in Figure 6, E154A and E158A mutations resulted in
350-fold and 160-fold reductions in decapping activity,
respectively. The results conﬁrm that the conserved
Nudix box in the AtDcp2 decapping enzyme is catalyti-
cally critical and that the mechanism of catalysis common
to the Nudix superfamily is conserved in hydrolysis of
capped mRNA carried out by this enzyme.
Dependency ofmRNA decapping onbinding to the
mRNA body
An mRNA body of 23 nucleotides has been shown to be
essential for decapping by the human hDcp2 protein (7).
The hDcp2 decapping enzyme is unable to hydrolyse cap
Figure 5. The eﬀect of ﬂuoride ions on mRNA decapping.
(A) Decapping activity of GST-AtDcp2-PD-His10 protein determined
in the presence and absence of 50–1000mM of NaF with 5mM Mn
2+
as the cofactor. Five micrograms of protein was used for each assay
(B) Time course of decapping catalysed by GST-AtDcp2-PD-His10 in
the presence and absence of 25mM NaF with 5mM Mn
2+ as the
cofactor. A total of 5mg of the protein was used for each assay.
(C) Decapping activity of GST-AtDcp2-PD-His10 protein in the
presence of 5mM Mg
2+ and 50mM to 25mM of NaF. SEM, standard
error of mean.
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7G(50)ppp(50)G and decapping of capped
mRNA by the hDcp2 enzyme is not inhibited by the
addition of cap analog as a competitor (7,12,17). Taken
together, these studies suggest the requirement of a
minimal number of nucleotides in the capped mRNA for
its recognition by hDcp2 as substrates. In addition,
uncapped transcripts are eﬃcient competitors of capped
mRNA in the hDcp2-catalysed decapping reaction,
suggesting that mRNA binding by hDcp2 can be
independent of the 7-methyl diguanosine triphosphate
cap (17). To determine whether the Arabidopsis AtDcp2
enzyme bound to the mRNA moiety of the capped mRNA
or to the cap, the GST-AtDcp2-PD-His10 protein was
assayed for decapping activity with a ﬁxed amount
(0.14nM) of [a-
32P] capped mRNA in the presence or
absence of 164mM of uncapped Omp mRNA or cap
analog as competitors. As shown in Table 1, production of
[a-
32P] 7-methyl GDP from [a-
32P] capped mRNA was
reduced by uncapped Omp mRNA even though it does
not have the 7-methyl diguanosine triphosphate cap. In
contrast, the cap analog, 7-methyl diguanosine tripho-
sphate, did not reduce mRNA decapping. From these
results, we conclude that the RNA strand rather than the
cap mediates binding of the capped mRNA to AtDcp2.
Such property is consistent with the mechanism proposed
by Piccirillo et al. (17) for the human decapping enzyme—
the decapping enzyme ﬁrst binds the RNA moiety of the
substrate and then scans the RNA body to locate the cap.
AtDcp2 activity is inhibitedby the reaction product
7-methyl GDP
In contrast to the inability of the 7-methyl diguanosine
triphosphate to inhibit AtDcp2 activity, the reaction
product 7-methyl GDP at 200mM eﬀectively suppressed
the AtDcp2-catalysed decapping activity (Table 1). Our
results suggest that the active site of the decapping enzyme
adopts a conﬁguration that binds poorly to the cap
structure of capped mRNA but relatively eﬃciently to the
reaction product 7-methyl GDP.
Deletion ofakey loopregion in theputative RNA-binding
domaininterferes withthe AtDcp2 catalysed decapping
activity
Multiple sequence alignment of Dcp2 enzymes from a
range of species was used to identify the RNA binding
domain in the AtDcp2 protein (Figure 7A). In the human
decapping enzyme, hDcp2, a region consisting of Box B
and the preceding loop region was shown to be important
for RNA binding (17). The Box B region is conserved
in the Dcp2-type decapping enzymes (Figure 7A). From
the structure of the Schizosaccharomyces pombe Dcp2p
enzyme, it is clear that Box B forms the C-terminal helix
Figure 6. Eﬀects of mutation of two conserved glutamates in the Nudix box on decapping activity of AtDcp2. (A) The mutated residues (underlined)
within the Nudix box. (B) Decapping activities of the GST-AtDcp2-PD-His10 protein and the mutants. The decapping assays were carried out with
8mg of puriﬁed recombinant enzyme from three separate expressions. SEM, standard error of mean.
Table 1. The dependency of decapping on mRNA/cap/product binding
Competitor Decapped (%) SEM (+/ )
Panel A
None 68.4 0.7






7-methyl GDP (2mM) 25.3 1.4
7-methyl GDP (0.2mM) 29.4 0.1
(A) The extent of decapping of the substrate was measured after 60min
in assays containing GST-AtDcp2-PD-His10 protein, 5mM Mn
2  and
a ﬁxed amount (0.14nM) of radiolabelled capped Omp mRNA,
supplemented with 164mM each of the competitors: uncapped Omp
and cap analog dinucleotide. The SEM of three separate assays for
each competitor are also indicated. All other conditions are as
described in the ‘Materials and methods’ section.
(B) The extent of decapping of the substrate by the recombinant
enzyme in the presence and absence of the reaction product 7-methyl
GDP after 60min.
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the structural features in the loop region preceding
the Box B region responsible for RNA binding, we
conducted bioinformatics analysis of this region in the
AtDcp2 sequence. The analysis revealed a motif
(VITHGVSGLKL) in this loop region of AtDcp2 that
closely resembles the VIGXXGXXUK segment
(Figure 7B) commonly found in the KH domain of
several RNA-binding proteins including ERA, Fragile X
protein, hnRNP K and Poly(C) binding proteins (42–45).
We therefore termed this motif as KH-like motif.
Homology modelling of the Nudix fold of the AtDcp2
protein (residues 98–250) using the known structure of the
S. pombe Dcp2p decapping enzyme, revealed that this
KH-like motif likely resides in the loop region that extends
to the start of the Box B helix (Figure 7C). We postulate
Figure 7. Eﬀects of mutation of residues within the putative RNA-binding KH-like domain and Box B domain on catalytic activity of AtDcp2.
(A) Sequence alignment of Arabidopsis thaliana (AtDcp2) to reveal the putative KH-like domain. Oryza sativa (osDcp2), human (hDcp2), Xenopus
laevis (xlDcp2) and Caenorhabditis elegans (ceDcp2) Dcp2 decapping enzymes were used for the alignments. The position of the KH-like motif and
Box B within the AtDcp2 protein is shown in the sequence alignment. (B) The consensus sequence of the conserved 10 residue region found in KH
domains (42,43), the sequence corresponding to the consensus sequence found in the KH domain in the RNA-binding site of ERA protein from
E. coli (42) and the sequence of a KH-like motif in the AtDcp2 decapping enzyme. (C) Comparison of the structure of the Ap4A hydrolase from
L. angustifolius (PDB ID–1JKN) with the homology model of the Nudix fold of the AtDcp2 protein (residues 98–250) modelled after the structure of
the S.pombe Dcp2p enzyme (PDB ID – 2A6T). Box B helix in the AtDcp2 homology model and the analogous helix 4 in the lupin enzyme structure
are marked in red. The 11-residue region forming the near-consensus of a KH motif, found within the loop region preceding Box B, is coloured in
yellow. This region was deleted in mutant AtDcp2
 222–232. The side chains of three lysines and a single glycine, which were mutated individually to
alanines, are also shown. (D) Decapping activities of the GST-AtDcp2-PD-His10 protein and the mutant proteins carrying mutations in the putative
RNA-binding site. All decapping eﬃciencies were obtained from decapping assays carried out using 8mg of recombinant enzyme from three separate
expressions. SEM, standard error of mean.
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determinants that facilitate the decapping reaction by
binding to the RNA moiety of the capped mRNA
substrate.
To ascertain the functional signiﬁcance of the 11-residue
KH-like motif, it was deleted or mutated in AtDcp2. As
shown in Figure 7D, deletion of the KH-like motif led to a
92-fold reduction in the decapping activity. Replacement
of Lys-231 and Gly-226 in this segment (VITHGVSGLK)
by alanine reduced the decapping activity of AtDcp2 by
 68% and 34%, respectively. In summary, our results
suggest that the KH-like motif contains determinants
essential for decapping activity. Presumably, these deter-
minants facilitate decapping by mediating association of
AtDcp2 with the RNA backbone of the capped mRNA
substrate. This notion is supported by comparison of the
homology model of the AtDcp2 protein with the structure
of the related Nudix enzyme Ap4A hydrolase from
Lupinus angustifolius (46,47). It was evident from the
comparison that the Box B helix of AtDcp2 is equivalent
to helix 4 in the lupin enzyme structure (Figure 7C). The
loop region preceding helix 4 in the lupin Ap4A hydrolase
was demonstrated to contribute critical substrate binding
residues that lined the hydrophobic pocket, where the
ATP-MgFX substrate bound (47). It is likely that the
KH-like motif in this loop region is suitably located in
the AtDcp2 structure to mediate or facilitate binding of
the decapping enzyme to the RNA substrate.
Twolysine residues inBoxB region contributeto efficient
hydrolysis of cappedmRNA byAtDcp2
Since the Box B region in human decapping enzyme was
found to participate in RNA binding, we conducted a
mutagenesis study to ascertain if the Box B region of
AtDcp2 contains determinants that are important for
activity. Both Lys-243 and Lys-248 in the Box B region of
AtDcp2 were individually modiﬁed to alanine to eliminate
their polar side chains. As shown in Figure 7D, the
mutations resulted in 56–68% reductions in decapping
activity (Figure 7D), supporting the notion that both
lysine residues in the Box B region contribute to the ability
of AtDcp2 to eﬃciently hydrolyse capped mRNA.
Presumably, the positively charged side chains of both
lysines mediate binding of AtDcp2 to the RNA moiety of
the capped mRNA substrate.
DISCUSSION
The roles of Glu-154 and Glu-158 inthe decapping reaction
This study describes the functional characterization of
a Dcp2 type decapping enzyme from plants. The AtDcp2
enzyme hydrolyses the mRNA cap by substitution at
b-phosphorus, the conserved mechanism of catalysis
for the Nudix superfamily, yielding 7-methyl GDP and
50-monophosphate mRNA as the products. The individual
conversion of both essential catalytic site glutamates,
Glu-154 and Glu-158, to alanine resulted in more
than 150-fold reductions in catalytic activity of the
AtDcp2 enzyme, consistent with their functions as
the eﬀector of catalysis (Glu-154) and a ligand donor
(Glu-158) that coordinates a divalent cation, respec-
tively (39). Relevant to our ﬁndings presented in
Figure 6, mutations of homologous glutamates in the
conserved Nudix box motif of both the human and
yeast decapping enzymes abolished their decapping
activities (7,11).
ImplicationsofproductinhibitionofAtDcp2by7-methylGDP
Decapping was inhibited by the product 7-methyl GDP,
by uncapped mRNA but not by the cap analog, 7-methyl
diguanosine triphosphate. It appears that presentation of
the cap to the cleavage site requires the cooperation of the
mRNA body and that the catalytic site binds to the
product 7-methyl GDP more strongly than to the cap in
capped mRNA. The 7-methyl GDP similarly inhibits the
inherent mRNA decapping activity in the L-A virus (48)
and the activity of the nuclear Nudix small nucleolar RNA
decapping enzyme X29 (49). Such product inhibition by
7-methyl GDP constitutes a potential mechanism to
prevent decapping of intact translatable mRNAs and
accordingly 7-methyl GDP has a short cellular lifetime.
The 7-methyl GDP formed by Dcp2 enzymes is converted
rapidly to 7-methyl GMP by the scavenger mRNA
decapping activity in vivo (50).
The lackof sensitivity tofluoride ions isadistinguishing
featureof AtDcp2 within theNudix hydrolasesuperfamily
ofenzymes
Extreme sensitivity to ﬂuoride has been shown previously
to be a widespread characteristic of Nudix hydrolases.
All enzymes so far tested have shown this (35,36,38,51).
Contrary to other Nudix enzymes, the AtDcp2 protein
was not inhibited by ﬂuoride ions at concentrations of up
to 1mM. Only at 25mM, did the ﬂuoride ions impose a
minor inhibitory eﬀect. Fluoride compounds mimic
phosphate groups. It has been proposed that Nudix
enzymes and ATPases are inhibited by complexes formed
with the ﬂuoride compounds and the reaction products
(36,52). Since our results demonstrate that AtDcp2 is
refractory to inhibition by ﬂuoride ions, we propose that
AtDcp2 active site adopts a conﬁguration with limited
accessibility to the complexes formed by ﬂuoride ions
with 7-methyl GDP. It is likely all other Dcp2-type
decapping enzymes also share such a property.
In this respect, the Dcp2-type decapping enzyme
appears to be distinct from many other Nudix hydrolases.
Future investigations to solve the 3D structure of
AtDcp2 will provide the structural basis for this distinct
property.
The structural basis of RNA binding by AtDcp2
RNA-binding proteins interact with RNA molecules in
two structurally deﬁned modes: (i) groove binding and
(ii) b-sheet binding (53,54). For the proteins adopting the
groove-binding mode, a secondary structural element such
as a helix or a loop is inserted into the groove of the RNA
substrate (53,54). It is proposed here that AtDcp2 adopts
the groove-binding mode to bind RNA—the loop region
preceding Box B and/or Box B extending into grooves of
the RNA molecule. Katsamba and co-workers (55)
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RNA association. In this model, electrostatic interactions
are the key for the initial association (the lure step).
This is then followed by rapid induced ﬁt binding (the lock
step), resulting in a stable protein–RNA complex (55).
Since mutation of Lys-231 in the loop region and Lys-243
and Lys-248 in the Box B region reduces the decapping
activity of AtDcp2 (Figure 7), we propose that they
are responsible for the initial electrostatic interactions
in the lure step to ‘lure’ the RNA molecule to AtDcp2,
the bound RNA molecule then induces conforma-
tional changes to establish additional interactions
between the RNA moiety with determinants in
other parts of AtDcp2 to form a stable protein–RNA
complex.
Piccirillo et al. (17) reported that the carboxyl-terminal
portion including Box B in the human decapping enzyme
hDcp2 can mediate RNA binding. They also demon-
strated that hDcp2 and single-stranded DNA could form
stable complexes, and the ability of hDcp2 to form the
complexes was signiﬁcantly diminished upon deletion of
the C-terminal segment containing Box B. We have
attempted to use the three diﬀerent methods described
by Piccirillo et al. (17) and Moller et al. (56) and to
ascertain if AtDcp2 can form stable complexes with
[a-
32P]-m
7Gppp-RNA. These methods include: (i) the
Northwestern RNA-binding assay, (ii) cross-linking of
AtDcp2 with [a-
32P]-m
7Gppp-RNA by ultraviolet light
irradiation and (iii) cross-linking of AtDcp2 with [a-
32P]-
m
7Gppp-RNA by formaldehyde treatment. In contrast to




A possible explanation for our failure to detect the
stable complexes is that the binding of AtDcp2 to
capped mRNA is transient in nature. An appropriate
approach for future studies to measure the aﬃnity of
AtDcp2 for capped mDNA and to deﬁne the structural
motifs critical for RNA binding is the use of surface
plasmon resonance to determine the aﬃnities of AtDcp2
and its mutants for capped mRNA immobilized on sensor
chips.
Possible functional significance of theputative PDZ
domain-bindingmotif atthe C-terminus of AtDcp2
Bioinformatics analysis identiﬁed the ‘GNSA’ motif at the
C-terminus of AtDcp2 as a putative PDZ domain-binding
motif. In addition, we conducted further analysis by
homology searches in the NCBI database and found that
similar putative PDZ domain-binding motifs also exist in
almost 80% of vertebrate and plant Dcp2 decapping
enzymes (data not shown). One approach to ascertain if
the GNSA can indeed mediate AtDcp2 binding to PDZ
domain-containing proteins is to use the recombinant
GST-AtDcp2 proteins as the baits to search for binding
proteins in Arabidopsis tissue lysates. Proteins that can
bind the GST-AtDcp2 but not GST-AtDcp2-PD
(Figure 1) are likely those that target the GNSA-motif.
Identiﬁcation of these proteins will shed light on
regulatory properties of AtDcp2.
CONCLUSIONS
Based upon the ﬁndings described in this article, we
propose a model of the catalytic mechanism and regula-
tion of AtDcp2 (Figure 8). We have demonstrated that
AtDcp2 catalyses the following reaction.
m7Gppp   RNA þ H2O ! m7GDP þ p   RNA þ Hþ
In the reaction, AtDcp2 selectively catalyses cleavage of
the diphosphate linkage between the b- and g-phosphates
in the cap of the capped mRNA substrate (m
7Gppp-
RNA) to generate 7-methyl GDP and 50-monophosphate
mRNA (p-RNA) as the reaction products. Similar to
other known Nudix hydrolase superfamily members, the
AtDcp2-catalysed decapping reaction involves nucleophi-
lic attack of the pyrophosphate bond by a water molecule
(Equation 1). One of the two conserved glutamates in the
Nudix box is involved in polarizing and appropriately
positioning the water molecule, while the other conserved
glutamate coordinates a divalent cation (Figure 8). It is
proposed that the recognition of the substrates by AtDcp2
involves binding of the RNA moiety of the capped mRNA
to the Box B region and a KH-like motif in the loop
preceding the Box B region. One lysine in the KH-like
motif and two lysines in the Box B region likely mediate
in part the binding of AtDcp2 to the RNA moiety.
Furthermore, the activity of AtDcp2 is subject to feedback
inhibition by its reaction product 7-methyl GDP and
uncapped RNA.
In spite of these ﬁndings, several important outstanding
questions remain: (i) What are the exact roles of Glu-154
and Glu-158 of the Nudix box in catalysis? (ii) How does
AtDcp2 selectively target the pyrophosphate bond linking
the b- and g-phosphates but not that linking the a- and
b-phosphates and the phosphoester linkage between
g-phosphate and the RNA moiety of the capped RNA
substrate? (iii) What is the structural basis of RNA
binding to the loop and Box B regions? (iv) How does the
active site of AtDcp2 target the cap at the 50-end of the
capped RNA substrates? (v) What are the upstream
regulators of AtDcp2? Xu et al. (8) recently reported that
AtDcp2 interacts with Dcp1 and VARICOSE (VCS), the
plant homolog of an important component called Hedls/
Ge-1 of the mRNA processing bodies (P bodies) in the
cytoplasm. Furthermore, they demonstrated that AtDcp2
activity is stimulated upon binding to these proteins.
Exactly how these regulatory proteins modulate AtDcp2
activity is unclear. The availability of the intact recombi-
nant AtDcp2 permits future investigation to answer these
questions by biochemical and structural approaches.
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